HEADER LIGASE 02-MAY-06 2CLW TITLE CRYSTAL STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBCH5B COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2 D2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UBCH5B, UBIQUITIN-PROTEIN LIGASE D2, UBIQUITIN CARRIER COMPND 5 PROTEIN D2, UBIQUITIN-CONJUGATING ENZYME E2-17 KDA 2, E2(17)KB 2; COMPND 6 EC: 6.3.2.19; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: RESIDUE A 85 HAS BEEN MODIFIED FROM CYSTEINE BY 2- COMPND 9 MERCAPTOETHANOL TO FORM S, S-(2-HYDROXYETHYL) THIOCYSTEINE; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2 D2; COMPND 12 CHAIN: B, C, D; COMPND 13 SYNONYM: UBCH5B, UBIQUITIN-PROTEIN LIGASE D2, UBIQUITIN CARRIER COMPND 14 PROTEIN D2, UBIQUITIN-CONJUGATING ENZYME E2-17 KDA 2, E2(17)KB 2; COMPND 15 EC: 6.3.2.19; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET VECTOR; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETM-12 (EMBL); SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 19 EXPRESSION_SYSTEM_VECTOR: PET VECTOR; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PETM-12 (EMBL) KEYWDS LIGASE, UBL CONJUGATION PATHWAY, UBC DOMAIN, THIOESTERIFICATION EXPDTA X-RAY DIFFRACTION AUTHOR R.B.DODD,R.J.READ REVDAT 4 13-DEC-23 2CLW 1 REMARK LINK REVDAT 3 13-AUG-14 2CLW 1 TITLE KEYWDS SPRSDE REMARK REVDAT 3 2 1 VERSN HETNAM FORMUL MASTER REVDAT 2 24-FEB-09 2CLW 1 VERSN REVDAT 1 12-JUN-07 2CLW 0 SPRSDE 13-AUG-14 2CLW 2C4O JRNL AUTH R.B.DODD,R.J.READ JRNL TITL STRUCTURES OF TWO HUMAN UBIQUITIN-CONJUGATING ENZYMES FROM JRNL TITL 2 TWINNED CRYSTALS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1418061.630 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 44131 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1116 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5223 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4798 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 270 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.44000 REMARK 3 B22 (A**2) : 1.06900 REMARK 3 B33 (A**2) : -3.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.44 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.150 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.580 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.330 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 77.07 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CME.PAR REMARK 3 PARAMETER FILE 5 : GOL.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_CME.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CME.TOP REMARK 3 TOPOLOGY FILE 5 : GOL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DUE TO THE PRESENCE OF ORTHORHOMBIC REMARK 3 PSEUDOSYMMETRY, THE TEST SET OF REFLECTIONS WERE CHOSEN IN REMARK 3 P212121 AND THEN EXPANDED TO COVER THE MONOCLINIC SPACE GROUP. REMARK 3 DATA WERE FOUND TO BE NEAR- PERFECTLY TWINNED AND WERE THEREFORE REMARK 3 TREATED AS PERFECTLY TWINNED. NCS RESTRAINTS WERE APPLIED DURING REMARK 3 REFINEMENT WITH POSITIONAL RESTRAINTS OF 30 KCAL/MOL-A**2 (300 REMARK 3 INITIALLY) AND B-FACTOR TARGET SIGMA OF 2. REMARK 4 REMARK 4 2CLW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1290028416. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9821 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 602165 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 30.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.360 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.27 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1QCQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 150 MM AMMONIUM SULPHATE, 100 MM REMARK 280 SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000, PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.90150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 RESPONSIBLE FOR THE UBIQUITINATION OF OTHER PROTEINS. REMARK 400 IT ALSO TAKES PART IN THE DEGRADATION OF ABNORMAL AND REMARK 400 SHORT-LIVED PROTEINS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -17 REMARK 465 LYS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 PRO A -9 REMARK 465 MET A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PRO A -3 REMARK 465 MET B -17 REMARK 465 LYS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 PRO B -9 REMARK 465 MET B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 LEU B -5 REMARK 465 VAL B -4 REMARK 465 PRO B -3 REMARK 465 MET C -17 REMARK 465 LYS C -16 REMARK 465 HIS C -15 REMARK 465 HIS C -14 REMARK 465 HIS C -13 REMARK 465 HIS C -12 REMARK 465 HIS C -11 REMARK 465 HIS C -10 REMARK 465 PRO C -9 REMARK 465 MET C -8 REMARK 465 SER C -7 REMARK 465 GLY C -6 REMARK 465 LEU C -5 REMARK 465 VAL C -4 REMARK 465 PRO C -3 REMARK 465 MET D -17 REMARK 465 LYS D -16 REMARK 465 HIS D -15 REMARK 465 HIS D -14 REMARK 465 HIS D -13 REMARK 465 HIS D -12 REMARK 465 HIS D -11 REMARK 465 HIS D -10 REMARK 465 PRO D -9 REMARK 465 MET D -8 REMARK 465 SER D -7 REMARK 465 GLY D -6 REMARK 465 LEU D -5 REMARK 465 VAL D -4 REMARK 465 PRO D -3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OXT MET C 147 O HOH C 2053 2.14 REMARK 500 NZ LYS D 144 O HOH D 2062 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 16 53.96 -146.75 REMARK 500 PRO A 17 109.84 -31.36 REMARK 500 ALA A 19 108.10 -59.30 REMARK 500 ARG A 90 -100.68 -147.01 REMARK 500 ASN A 114 77.46 -115.18 REMARK 500 ASP A 117 73.13 -117.03 REMARK 500 ASP A 130 68.43 -154.35 REMARK 500 ARG B 90 -100.78 -147.23 REMARK 500 ASP B 130 64.77 -161.61 REMARK 500 GLN C 20 19.21 59.44 REMARK 500 THR C 58 8.42 -63.18 REMARK 500 ARG C 90 -85.66 -154.26 REMARK 500 ASP C 117 70.36 -110.06 REMARK 500 ASP C 130 61.28 -158.81 REMARK 500 SER D 0 -82.44 -56.72 REMARK 500 ASP D 16 69.65 -155.66 REMARK 500 GLN D 20 40.42 -175.69 REMARK 500 PRO D 44 0.39 -61.21 REMARK 500 THR D 58 28.68 -77.98 REMARK 500 ARG D 90 -79.87 -158.09 REMARK 500 ASP D 117 72.02 -117.02 REMARK 500 ASP D 130 72.84 -160.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1149 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1150 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 1148 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UR6 RELATED DB: PDB REMARK 900 NMR BASED STRUCTURAL MODEL OF THE UBCH5B- CNOT4 COMPLEX REMARK 900 RELATED ID: 1W4U RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE UBIQUITIN CONJUGATING ENZYME UBCH5B REMARK 900 RELATED ID: 2C4O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN UBIQUITIN- CONJUGATING ENZYME UBCH5B REMARK 900 RELATED ID: 2ESK RELATED DB: PDB REMARK 900 HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B , WILD-TYPE REMARK 900 RELATED ID: 2ESO RELATED DB: PDB REMARK 900 HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTILE37ALA REMARK 900 RELATED ID: 2ESP RELATED DB: PDB REMARK 900 HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTILE88ALA REMARK 900 RELATED ID: 2ESQ RELATED DB: PDB REMARK 900 HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTSER94GLY REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN ADDITION TO THE RGS SEQUENCE PRECEDING THE UNIPROT REMARK 999 UBCH5B SEQUENCE, THE FOLLOWING RESIDUES WERE PRESENT REMARK 999 IN THE STRUCTURE, BUT NOT LOCATED IN THE ELECTRON REMARK 999 DENSITY MAPS,PRESUMABLY DUE TO DISORDER: REMARK 999 MKHHHHHHPMSGLVP DBREF 2CLW A -17 0 PDB 2CLW 2CLW -17 0 DBREF 2CLW A 1 147 UNP P62837 UB2D2_HUMAN 1 147 DBREF 2CLW B -17 0 PDB 2CLW 2CLW -17 0 DBREF 2CLW B 1 147 UNP P62837 UB2D2_HUMAN 1 147 DBREF 2CLW C -17 0 PDB 2CLW 2CLW -17 0 DBREF 2CLW C 1 147 UNP P62837 UB2D2_HUMAN 1 147 DBREF 2CLW D -17 0 PDB 2CLW 2CLW -17 0 DBREF 2CLW D 1 147 UNP P62837 UB2D2_HUMAN 1 147 SEQRES 1 A 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 A 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE HIS LYS SEQRES 3 A 165 GLU LEU ASN ASP LEU ALA ARG ASP PRO PRO ALA GLN CYS SEQRES 4 A 165 SER ALA GLY PRO VAL GLY ASP ASP MET PHE HIS TRP GLN SEQRES 5 A 165 ALA THR ILE MET GLY PRO ASN ASP SER PRO TYR GLN GLY SEQRES 6 A 165 GLY VAL PHE PHE LEU THR ILE HIS PHE PRO THR ASP TYR SEQRES 7 A 165 PRO PHE LYS PRO PRO LYS VAL ALA PHE THR THR ARG ILE SEQRES 8 A 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CME LEU SEQRES 9 A 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR ILE SEQRES 10 A 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 A 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO GLU ILE ALA ARG SEQRES 12 A 165 ILE TYR LYS THR ASP ARG GLU LYS TYR ASN ARG ILE ALA SEQRES 13 A 165 ARG GLU TRP THR GLN LYS TYR ALA MET SEQRES 1 B 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 B 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE HIS LYS SEQRES 3 B 165 GLU LEU ASN ASP LEU ALA ARG ASP PRO PRO ALA GLN CYS SEQRES 4 B 165 SER ALA GLY PRO VAL GLY ASP ASP MET PHE HIS TRP GLN SEQRES 5 B 165 ALA THR ILE MET GLY PRO ASN ASP SER PRO TYR GLN GLY SEQRES 6 B 165 GLY VAL PHE PHE LEU THR ILE HIS PHE PRO THR ASP TYR SEQRES 7 B 165 PRO PHE LYS PRO PRO LYS VAL ALA PHE THR THR ARG ILE SEQRES 8 B 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CYS LEU SEQRES 9 B 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR ILE SEQRES 10 B 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 B 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO GLU ILE ALA ARG SEQRES 12 B 165 ILE TYR LYS THR ASP ARG GLU LYS TYR ASN ARG ILE ALA SEQRES 13 B 165 ARG GLU TRP THR GLN LYS TYR ALA MET SEQRES 1 C 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 C 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE HIS LYS SEQRES 3 C 165 GLU LEU ASN ASP LEU ALA ARG ASP PRO PRO ALA GLN CYS SEQRES 4 C 165 SER ALA GLY PRO VAL GLY ASP ASP MET PHE HIS TRP GLN SEQRES 5 C 165 ALA THR ILE MET GLY PRO ASN ASP SER PRO TYR GLN GLY SEQRES 6 C 165 GLY VAL PHE PHE LEU THR ILE HIS PHE PRO THR ASP TYR SEQRES 7 C 165 PRO PHE LYS PRO PRO LYS VAL ALA PHE THR THR ARG ILE SEQRES 8 C 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CYS LEU SEQRES 9 C 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR ILE SEQRES 10 C 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 C 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO GLU ILE ALA ARG SEQRES 12 C 165 ILE TYR LYS THR ASP ARG GLU LYS TYR ASN ARG ILE ALA SEQRES 13 C 165 ARG GLU TRP THR GLN LYS TYR ALA MET SEQRES 1 D 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 D 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE HIS LYS SEQRES 3 D 165 GLU LEU ASN ASP LEU ALA ARG ASP PRO PRO ALA GLN CYS SEQRES 4 D 165 SER ALA GLY PRO VAL GLY ASP ASP MET PHE HIS TRP GLN SEQRES 5 D 165 ALA THR ILE MET GLY PRO ASN ASP SER PRO TYR GLN GLY SEQRES 6 D 165 GLY VAL PHE PHE LEU THR ILE HIS PHE PRO THR ASP TYR SEQRES 7 D 165 PRO PHE LYS PRO PRO LYS VAL ALA PHE THR THR ARG ILE SEQRES 8 D 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CYS LEU SEQRES 9 D 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR ILE SEQRES 10 D 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 D 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO GLU ILE ALA ARG SEQRES 12 D 165 ILE TYR LYS THR ASP ARG GLU LYS TYR ASN ARG ILE ALA SEQRES 13 D 165 ARG GLU TRP THR GLN LYS TYR ALA MET MODRES 2CLW CME A 85 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 85 10 HET SO4 A1148 5 HET GOL A1149 6 HET GOL A1150 6 HET GOL D1148 6 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 5 SO4 O4 S 2- FORMUL 6 GOL 3(C3 H8 O3) FORMUL 9 HOH *270(H2 O) HELIX 1 1 ARG A -2 ARG A 15 1 18 HELIX 2 2 LEU A 86 ARG A 90 5 5 HELIX 3 3 THR A 98 ASP A 112 1 15 HELIX 4 4 VAL A 120 ASP A 130 1 11 HELIX 5 5 ASP A 130 TYR A 145 1 16 HELIX 6 6 GLY B -1 ASP B 16 1 18 HELIX 7 7 LEU B 86 ARG B 90 5 5 HELIX 8 8 THR B 98 ASP B 112 1 15 HELIX 9 9 VAL B 120 ASP B 130 1 11 HELIX 10 10 ASP B 130 ALA B 146 1 17 HELIX 11 11 SER C 0 ASP C 16 1 17 HELIX 12 12 LEU C 86 ARG C 90 5 5 HELIX 13 13 THR C 98 ASP C 112 1 15 HELIX 14 14 VAL C 120 ASP C 130 1 11 HELIX 15 15 ASP C 130 ALA C 146 1 17 HELIX 16 16 ARG D -2 ASP D 16 1 19 HELIX 17 17 LEU D 86 ARG D 90 5 5 HELIX 18 18 THR D 98 ASP D 112 1 15 HELIX 19 19 VAL D 120 ASP D 130 1 11 HELIX 20 20 ASP D 130 ALA D 146 1 17 SHEET 1 AA 4 CYS A 21 PRO A 25 0 SHEET 2 AA 4 HIS A 32 MET A 38 -1 O GLN A 34 N GLY A 24 SHEET 3 AA 4 VAL A 49 HIS A 55 -1 O PHE A 50 N ILE A 37 SHEET 4 AA 4 LYS A 66 PHE A 69 -1 O LYS A 66 N HIS A 55 SHEET 1 BA 4 CYS B 21 PRO B 25 0 SHEET 2 BA 4 HIS B 32 MET B 38 -1 O GLN B 34 N GLY B 24 SHEET 3 BA 4 VAL B 49 HIS B 55 -1 O PHE B 50 N ILE B 37 SHEET 4 BA 4 LYS B 66 PHE B 69 -1 O LYS B 66 N HIS B 55 SHEET 1 CA 4 CYS C 21 PRO C 25 0 SHEET 2 CA 4 HIS C 32 MET C 38 -1 O GLN C 34 N GLY C 24 SHEET 3 CA 4 VAL C 49 HIS C 55 -1 O PHE C 50 N ILE C 37 SHEET 4 CA 4 LYS C 66 PHE C 69 -1 O LYS C 66 N HIS C 55 SHEET 1 DA 4 CYS D 21 PRO D 25 0 SHEET 2 DA 4 HIS D 32 MET D 38 -1 O GLN D 34 N GLY D 24 SHEET 3 DA 4 VAL D 49 HIS D 55 -1 O PHE D 50 N ILE D 37 SHEET 4 DA 4 LYS D 66 PHE D 69 -1 O LYS D 66 N HIS D 55 LINK C ILE A 84 N CME A 85 1555 1555 1.33 LINK C CME A 85 N LEU A 86 1555 1555 1.34 CISPEP 1 TYR A 60 PRO A 61 0 -0.41 CISPEP 2 TYR B 60 PRO B 61 0 0.01 CISPEP 3 TYR C 60 PRO C 61 0 0.26 CISPEP 4 TYR D 60 PRO D 61 0 0.08 SITE 1 AC1 4 LYS A 133 ARG A 136 HOH A2083 HOH A2084 SITE 1 AC2 8 CYS A 111 TYR A 127 ARG A 131 HOH A2071 SITE 2 AC2 8 ARG D 5 ALA D 96 THR D 98 HOH D2044 SITE 1 AC3 1 HOH A2056 SITE 1 AC4 4 LYS B 133 ARG B 136 ASN D 11 ARG D 15 CRYST1 45.585 65.803 101.677 90.00 89.96 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021937 0.000000 -0.000015 0.00000 SCALE2 0.000000 0.015197 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009835 0.00000 MTRIX1 1 -0.999820 0.007240 -0.017670 22.33517 1 MTRIX2 1 -0.006760 -0.999610 -0.027250 27.01925 1 MTRIX3 1 -0.017860 -0.027130 0.999470 -24.26884 1 MTRIX1 2 0.996090 0.002870 0.088300 -3.92320 1 MTRIX2 2 -0.004040 0.999910 0.013070 -0.24234 1 MTRIX3 2 -0.088250 -0.013370 0.996010 -50.41184 1 MTRIX1 3 0.992730 -0.028480 -0.116980 -18.54609 1 MTRIX2 3 -0.032810 -0.998840 -0.035250 -4.85658 1 MTRIX3 3 -0.115840 0.038830 -0.992510 28.47761 1